Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sangamo Therapeutics (SGMO)

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 867,216
  • Shares Outstanding, K 115,938
  • Annual Sales, $ 84,450 K
  • Annual Income, $ -68,330 K
  • 60-Month Beta 2.79
  • Price/Sales 10.93
  • Price/Cash Flow N/A
  • Price/Book 2.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.31
  • Number of Estimates 5
  • High Estimate -0.27
  • Low Estimate -0.42
  • Prior Year -0.18
  • Growth Rate Est. (year over year) -72.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.95 +1.43%
on 01/31/20
8.47 -16.79%
on 01/21/20
-1.32 (-15.77%)
since 01/17/20
3-Month
6.95 +1.43%
on 01/31/20
12.33 -42.82%
on 12/09/19
-2.63 (-27.17%)
since 11/19/19
52-Week
6.95 +1.43%
on 01/31/20
13.91 -49.32%
on 04/02/19
-1.67 (-19.15%)
since 02/19/19

Most Recent Stories

More News
Shares of SGMO Down 21.4% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Sangamo Therapeu (NASDAQ:SGMO) on December 10th, 2019 at $9.63. In approximately 2 months, Sangamo Therapeu has returned 21.35% as of today's recent price of $7.57....

SGMO : 7.05 (-5.75%)
Sangamo Therapeu Falls 3.87% on Heavy Volume: Watch For Potential Rebound

Sangamo Therapeu (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $7.45 to a high of $7.73. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $7.49...

SGMO : 7.05 (-5.75%)
Sangamo Therapeutics Appoints John Markels to Its Board of Directors

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of Dr. John Markels, an accomplished pharmaceutical executive with three decades of general management,...

MRK : 82.60 (+0.17%)
SGMO : 7.05 (-5.75%)
Sangamo Therapeu Shares Down 24.2% Since SmarTrend's Sell Call (SGMO)

SmarTrend identified a Downtrend for Sangamo Therapeu (NASDAQ:SGMO) on December 10th, 2019 at $9.63. In approximately 2 months, Sangamo Therapeu has returned 24.16% as of today's recent price of $7.30....

SGMO : 7.05 (-5.75%)
Novavax Inc has the Best Relative Performance in the Biotechnology Industry (NVAX , XLRN , SGMO , UTHR , CVM)

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

XLRN : 94.31 (+0.69%)
NVAX : 7.95 (-0.50%)
SGMO : 7.05 (-5.75%)
17.8% Return Seen to Date on SmarTrend Sangamo Therapeu Call (SGMO)

SmarTrend identified a Downtrend for Sangamo Therapeu (NASDAQ:SGMO) on December 10th, 2019 at $9.63. In approximately 2 month, Sangamo Therapeu has returned 17.77% as of today's recent price of $7.92....

SGMO : 7.05 (-5.75%)
Sangamo Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 38th Annual J.P. Morgan Healthcare Conference...

JPM : 136.20 (+0.41%)
SGMO : 7.05 (-5.75%)
Clovis Oncology has the Best Relative Performance in the Biotechnology Industry (CLVS , EPZM , SGMO , NVTA , FOLD )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

CLVS : 9.38 (+1.30%)
EPZM : 25.25 (+4.08%)
SGMO : 7.05 (-5.75%)
Look for Shares of Sangamo Therapeu to Potentially Rebound after Yesterday's 2.23% Sell Off

Sangamo Therapeu (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $8.31 to a high of $8.61. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $8.35...

SGMO : 7.05 (-5.75%)
BioMarin Files BLA for Gene Therapy to Treat Hemophilia A

BioMarin (BMRN) submits a BLA in the United States for its investigational gene therapy valoctocogene roxaparvovec to treat adult patients with severe hemophilia A.

PFE : 36.38 (+0.17%)
BMRN : 88.94 (-0.08%)
QURE : 62.71 (-0.76%)
SGMO : 7.05 (-5.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Trade SGMO with:

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

2nd Resistance Point 7.68
1st Resistance Point 7.58
Last Price 7.05
1st Support Level 7.38
2nd Support Level 7.28

See More

52-Week High 13.91
Fibonacci 61.8% 11.25
Fibonacci 50% 10.43
Fibonacci 38.2% 9.61
Last Price 7.05
52-Week Low 6.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar